Search Results
Results found for "Jillian G Baker"
- Adenosine receptor signalling in Alzheimer's disease
Emerging evidence suggests adenosine G protein-coupled receptors (GPCRs) are promising therapeutic targets
- GPR110, a receptor for synaptamide, expressed in osteoclasts negatively regulates osteoclastogenesis
Although some G-protein coupled receptors (GPCRs) were reported to play roles in osteoblast function,
- TAS2R supports odontoblastic differentiation of human dental pulp stem cells in the inflammatory...
The G protein and intracellular Ca2+ were detected, respectively, by qPCR and Fluo-4AM Ca2+ fluorescent
- Isoform-and ligand-specific modulation of adhesion GPCR ADGRL3/Latrophilin3 by a synthetic binder
September 2022 "Adhesion G protein-coupled receptors (aGPCRs) are cell-surface proteins with large extracellular
- Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine..
Chemokine Receptor CXCR3 for Autoimmune Diseases "The chemokine receptor CXCR3 is a seven-transmembrane G-protein-coupled
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
Numerous intracellular mediators are activated by these G protein-coupled receptors based on several
- Endogenous ligand recognition and structural transition of a human PTH receptor
PTH-related peptide (PTHrP) bind to the parathyroid hormone receptor 1 (PTH1R) and activate the stimulatory G-protein
- Label-free LC-MS based assay to characterize small molecule compound binding to cells
In one example, to study a G protein coupled receptor (GPCR), we used one antagonist as probe and multiple
- Allosteric Effect of Nanobody Binding on Ligand-Specific Active States of the β2 Adrenergic Receptor
Nanobody binding stabilizes G-protein-coupled receptors (GPCR) in a fully active state and modulates binding site and the extracellular domains in conformations modulated by a full agonist, BI167107, and a G-protein-biased
- Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases
Numerous intracellular mediators are activated by these G protein-coupled receptors based on several
- GPCR kinases generate an APH1A phosphorylation barcode to regulate amyloid-β generation
August 2022 "Emerging evidence suggests that G protein-coupled receptor (GPCR) kinases (GRKs) are associated
- Multifunctional role of GPCR signaling in epithelial tube formation
Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface.
- Domain Therapeutics and Explicyte enter partnership agreement in immuno-oncology
Therapeutics, a biopharmaceutical company specializing in the discovery and development of new drugs targeting G
- Multifunctional role of GPCR signaling in epithelial tube formation
Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface.
- Molecular mechanism of allosteric modulation for the cannabinoid receptor CB1
September 2022 "Given the promising clinical value of allosteric modulators of G protein-coupled-receptors
- Cholesterol occupies the lipid translocation pathway to block phospholipid scrambling by a GPCR
September 2022 "Class A (rhodopsin-like) G protein-coupled receptors (GPCRs) are constitutive phospholipid
- Endogenous ligand recognition and structural transition of a human PTH receptor
PTH-related peptide (PTHrP) bind to the parathyroid hormone receptor 1 (PTH1R) and activate the stimulatory G-protein
- Pharmacology at Your Fingertips: Terry’s Corner Launches
Gq Signaling Cryo-EM structures of Gq-bound PTH1R uncover glycan and loop-based mechanisms shaping G-protein
- The Gluopsins: Opsins without the Retinal Binding Lysine
They are G-protein-coupled receptors and bind as ligand retinal, which is bound covalently to a lysine
- Membrane Lipids Are an Integral Part of Transmembrane Allosteric Sites in GPCRs: A Case Study of...
Cannabinoid CB1 Receptor Bound to a Negative Allosteric Modulator, ORG27569, and Analogs "A growing number of G-protein-coupled
- Orion Announces The Rapid Lead Optimization Of Ob-004 - A Ccr2 Antagonist
. 30, 2021 -- Orion Biotechnology, a clinical stage company unlocking the therapeutic potential of G
- Fluorescent Ligands Targeting Intracellular Allosteric Binding Site of the Chemokine Receptor CCR2
August 2022 "Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors
- Tracking receptor motions at the plasma membrane reveals distinct effects of ligands on CCR5...
August 2022 "G-protein-coupled receptors (GPCR) are present at the cell surface in different conformational
- Dopamine D 1 receptor-mediated β-arrestin signaling: Insight from pharmacology, biology, behavior...
A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent
- Orion Shares New Data on its Latest Best-in-Class Drug Candidate
Biotechnology Canada Ltd, a drug discovery and development company unlocking the therapeutic potential of G
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute
- 📰 GPCR Weekly News, June 5 to 11, 2023
Hexahydroquinoline Derivatives are Selective Agonists for the Adhesion G Protein-Coupled Receptor ADGRG1 The G protein-coupled receptor neuropeptide receptor-15 modulates larval development via the transforming
- RAB-Symposium - Regulatory Autoantibodies Targeting GPCRs. September 15-16, 2022. Lübeck, Germany...
gives me great pleasure to announce the fourth hybrid symposium on regulatory autoantibodies targeting G-protein-coupled
- 📰 GPCR Weekly News, August 14 to 20, 2023
to 20, 2023 Adhesion GPCRs Amelioration of non-alcoholic fatty liver disease by targeting adhesion G that a glucagon-bound extracellular domain of the glucagon receptor is dynamic Ligand recognition and G
- VIB spin-off Confo Therapeutics Enters Collaborative Agreement with Regeneron
platform, which uses conformationally selective VHH antibodies – ConfoBodies® – to stabilize GPCRs (G

